Antoaneta Gateva

893 total citations
57 papers, 626 citations indexed

About

Antoaneta Gateva is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Antoaneta Gateva has authored 57 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Reproductive Medicine and 14 papers in Epidemiology. Recurrent topics in Antoaneta Gateva's work include Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (8 papers) and Adipose Tissue and Metabolism (8 papers). Antoaneta Gateva is often cited by papers focused on Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (8 papers) and Adipose Tissue and Metabolism (8 papers). Antoaneta Gateva collaborates with scholars based in Bulgaria, Japan and Italy. Antoaneta Gateva's co-authors include Zdravko Kamenov, Yavor Assyov, Adelina Tsakova, Tsvetelina Velikova, Vittorio Unfer, Alessandro D. Genazzani, Gianfranco Carlomagno, Latchezar Traykov, Shima Mehrabian and Gergana Todorova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Journal of the Neurological Sciences.

In The Last Decade

Antoaneta Gateva

55 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antoaneta Gateva Bulgaria 15 199 153 148 133 114 57 626
Carmine Bruno Italy 12 132 0.7× 81 0.5× 153 1.0× 81 0.6× 77 0.7× 46 404
Guadalupe Navarro United States 11 124 0.6× 92 0.6× 277 1.9× 156 1.2× 183 1.6× 12 689
Barbara Obermayer-Pietsch Austria 12 491 2.5× 298 1.9× 333 2.3× 142 1.1× 189 1.7× 23 1.1k
Cheryl Danton United States 5 92 0.5× 59 0.4× 71 0.5× 199 1.5× 174 1.5× 5 589
Yuyang Zhang China 14 86 0.4× 47 0.3× 109 0.7× 104 0.8× 116 1.0× 87 670
Jelica Bjekić-Macut Serbia 18 662 3.3× 369 2.4× 240 1.6× 81 0.6× 131 1.1× 45 1.0k
Mauro Abi Haidar Brazil 12 152 0.8× 124 0.8× 174 1.2× 33 0.2× 52 0.5× 33 571
Anna Noczyńska Poland 16 61 0.3× 53 0.3× 258 1.7× 113 0.8× 141 1.2× 84 818
Pierre Dupont Canada 9 98 0.5× 93 0.6× 342 2.3× 308 2.3× 83 0.7× 15 772
Soulmaz Shorakae Australia 15 587 2.9× 380 2.5× 165 1.1× 87 0.7× 72 0.6× 27 892

Countries citing papers authored by Antoaneta Gateva

Since Specialization
Citations

This map shows the geographic impact of Antoaneta Gateva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoaneta Gateva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoaneta Gateva more than expected).

Fields of papers citing papers by Antoaneta Gateva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoaneta Gateva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoaneta Gateva. The network helps show where Antoaneta Gateva may publish in the future.

Co-authorship network of co-authors of Antoaneta Gateva

This figure shows the co-authorship network connecting the top 25 collaborators of Antoaneta Gateva. A scholar is included among the top collaborators of Antoaneta Gateva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoaneta Gateva. Antoaneta Gateva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Assyov, Yavor, et al.. (2024). The impact of dietary intervention on myokines: a narrative review. Pharmacia. 71. 1–10.
3.
Gateva, Antoaneta, Tsvetelina Velikova, Tsvetoslav Georgiev, et al.. (2024). Meteorin-like Protein and Zonulin in Polycystic Ovary Syndrome: Exploring Associations with Obesity, Metabolic Parameters, and Inflammation. Biomedicines. 12(1). 222–222. 2 indexed citations
4.
Boyanov, Mihail, et al.. (2023). Biochemical Control of 78 Patients with Chronic Hypoparathyroidism Referred between 2006 and 2020 – Where do We Actually Stand?. SHILAP Revista de lepidopterología. 50(1). 5–12. 1 indexed citations
5.
Gateva, Antoaneta, et al.. (2022). Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes. Cannabis and Cannabinoid Research. 8(4). 634–641. 5 indexed citations
6.
Assyov, Yavor, et al.. (2021). Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. The Turkish Journal of Gastroenterology. 33(3). 233–239. 7 indexed citations
7.
Assyov, Yavor, et al.. (2021). Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders. 20(2). 132–136. 11 indexed citations
8.
Gateva, Antoaneta, et al.. (2021). Neopterin in the Evolution from Obesity to Prediabetes and Newly Diagnosed Type 2 Diabetes. Metabolic Syndrome and Related Disorders. 19(4). 249–255. 1 indexed citations
9.
Gateva, Antoaneta, et al.. (2020). Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes. Metabolic Syndrome and Related Disorders. 18(9). 443–448. 3 indexed citations
10.
Gateva, Antoaneta, et al.. (2019). PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes. Journal of Gastrointestinal and Liver Diseases. 28(4). 433–438. 15 indexed citations
11.
Gateva, Antoaneta, et al.. (2019). The role of Sudoscan feet asymmetry in the diabetic foot. Primary care diabetes. 14(1). 47–52. 12 indexed citations
12.
Gateva, Antoaneta, Tsvetelina Velikova, & Zdravko Kamenov. (2019). Peroxiredoxin 4 levels in patients with PCOS and/or obesity. Journal of Gynecology Obstetrics and Human Reproduction. 48(9). 739–743. 7 indexed citations
13.
Gateva, Antoaneta, Yavor Assyov, Adelina Tsakova, & Zdravko Kamenov. (2018). Classical (adiponectin, leptin, resistin) and new (chemerin, vaspin, omentin) adipocytokines in patients with prediabetes. Hormone Molecular Biology and Clinical Investigation. 34(1). 21 indexed citations
14.
Lozanov, Valentin, et al.. (2017). Serum anti-α-crystallin antibodies in women with endocrine disorders. Biotechnology & Biotechnological Equipment. 31(3). 574–580. 4 indexed citations
15.
Kamenov, Zdravko, et al.. (2017). Irisin and Testosterone in Men with Metabolic Syndrome. Hormone and Metabolic Research. 49(10). 755–759. 18 indexed citations
16.
Gateva, Antoaneta, Yavor Assyov, Adelina Tsakova, & Zdravko Kamenov. (2016). Soluble CD40L is associated with insulin resistance, but not with glucose tolerance in obese nondiabetic patients. Archives of Physiology and Biochemistry. 122(3). 161–165. 5 indexed citations
17.
Gateva, Antoaneta, Zdravko Kamenov, & Adelina Tsakova. (2013). NT-proBNP levels in premenopausal women with polycystic ovarian syndrome and/or obesity. Journal of Obstetrics and Gynaecology. 33(8). 868–872. 3 indexed citations
18.
Gateva, Antoaneta & Zdravko Kamenov. (2012). Anthropometric indices of visceral obesity and cardiovascular risk factors in patients with polycystic ovarian syndrome. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations
19.
Gateva, Antoaneta & Zdravko Kamenov. (2012). Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 164(2). 161–166. 17 indexed citations
20.
Tsakova, Adelina, Antoaneta Gateva, & Zdravko Kamenov. (2012). 25(OH) Vitamin D Levels in Premenopausal Women with Polycystic Ovary Syndrome and/or Obesity. International Journal for Vitamin and Nutrition Research. 82(6). 399–404. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmine Bruno Breakdown of academic impact, for papers by Guadalupe Navarro Breakdown of academic impact, for papers by Barbara Obermayer-Pietsch Breakdown of academic impact, for papers by Cheryl Danton Breakdown of academic impact, for papers by Yuyang Zhang Breakdown of academic impact, for papers by Jelica Bjekić-Macut Breakdown of academic impact, for papers by Mauro Abi Haidar Breakdown of academic impact, for papers by Anna Noczyńska Breakdown of academic impact, for papers by Pierre Dupont Breakdown of academic impact, for papers by Soulmaz Shorakae
Rankless by CCL
2026